Daniell, H.; Wakade, G.; Nair, S.K.; Singh, R.; Emanuel, S.A.; Brock, B.; Margulies, K.B.
Evaluation of Biologics ACE2/Ang(1–7) Encapsulated in Plant Cells for FDA Approval: Safety and Toxicology Studies. Pharmaceutics 2025, 17, 12.
https://doi.org/10.3390/pharmaceutics17010012
AMA Style
Daniell H, Wakade G, Nair SK, Singh R, Emanuel SA, Brock B, Margulies KB.
Evaluation of Biologics ACE2/Ang(1–7) Encapsulated in Plant Cells for FDA Approval: Safety and Toxicology Studies. Pharmaceutics. 2025; 17(1):12.
https://doi.org/10.3390/pharmaceutics17010012
Chicago/Turabian Style
Daniell, Henry, Geetanjali Wakade, Smruti K. Nair, Rahul Singh, Steven A. Emanuel, Barry Brock, and Kenneth B. Margulies.
2025. "Evaluation of Biologics ACE2/Ang(1–7) Encapsulated in Plant Cells for FDA Approval: Safety and Toxicology Studies" Pharmaceutics 17, no. 1: 12.
https://doi.org/10.3390/pharmaceutics17010012
APA Style
Daniell, H., Wakade, G., Nair, S. K., Singh, R., Emanuel, S. A., Brock, B., & Margulies, K. B.
(2025). Evaluation of Biologics ACE2/Ang(1–7) Encapsulated in Plant Cells for FDA Approval: Safety and Toxicology Studies. Pharmaceutics, 17(1), 12.
https://doi.org/10.3390/pharmaceutics17010012